CollabRx and Cynvenio Partner in Molecular Diagnostics for Cancer
11 déc. 2013 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Dec. 11, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Cynvenio Biosystems,...
CollabRx to Present at the LD MICRO Sixth Annual Conference
20 nov. 2013 14h36 HE
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 20, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Reports Second Quarter Fiscal Year 2014 Financial Results
13 nov. 2013 16h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the second quarter of fiscal year 2014, which ended September 30,...
CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing
11 nov. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 11, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a...
CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference Call and Business Update
05 nov. 2013 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on November...
CollabRx to Present at LD MICRO Invitational on October 2nd
26 sept. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Sept. 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
CollabRx Appoints George Lundberg, M.D. as Chief Medical Officer
04 sept. 2013 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Sept. 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the appointment of George Lundberg, M.D. as its Chief Medical Officer. Dr. Lundberg will continue in his...
CollabRx Reports First Quarter Fiscal Year 2014 Financial Results
13 août 2013 16h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the first quarter of fiscal year 2014, which ended June 30,...
CollabRx Announces Oncology-Specific Mobile App With Leading Site for Healthcare Professionals, MedPage Today
13 août 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a healthcare information technology company focused on informing clinical decision making in molecular medicine, today...
CollabRx Launches Commercial Service for the Interpretation of Clinical Cancer Sequencing
08 août 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 8, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the launch...